about
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle ...
Read More
78.64
1.42
(1.84%)
2.3M
XNAS Volume
XNAS 14 May, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Cytokinetics Inc is on 19 May 2026 for the purpose of RBC Capital Markets Global Healthcare Conference
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Cytokinetics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..